Specialties

The body is exposed to extremely low temperatures during Whole Body Cryotherapy (WBC), which results in a generalised anti-inflammatory response. This method was originally used to treat rheumatoid arthritis in Japan in 1978. WBC is a potent treatment for inflammatory diseases and injuries, according to studies done in Europe over the past 20 years. The procedures have been used to reverse skin ageing, increase collagen synthesis, improve skin elasticity and texture, and lessen the appearance of cellulite. WBC increases metabolic rate, which hastens weight reduction results. WBC is a potent medication that professional athletes have used to shorten recuperation times and improve sports performance.

Background Founded in 2009

In 2009, Cryohealthcare was one of the first businesses to introduce cryotherapy to the country. With the company’s headquarters in Los Angeles, California, Medical Director and Co-Founder Jonas Kuehne, M.D., a 2003 UCLA School of Medicine graduate, was the first doctor to provide this treatment in Northern America. The CryofacialTM procedure was created and trademarked by Dr. Kuehne, who also established standards for therapeutic efficacy and safety ever since it was first offered. In order to collaborate on the development of the industry’s top-of-the-line cryotherapy equipment, Cryohealthcare incorporated an engineering department to the business in 2011. Paul Sauer is a senior mechanical engineer. As a result, with distribution in the United States, Canada, Mexico, and Germany, Cryohealthcare was named the official and countrywide distributor of the top cryotherapy equipment available today. In 2013, Cryohealthcare changed its name to Cryomachines Inc., built offices in Canada and Germany, and put a stronger emphasis on distribution and first-rate equipment support.